Literature DB >> 31307199

miRNA and mRNA expression profiles in gastric cancer patients and the relationship with circRNA.

F Jiang1,2, X B Shen1,2.   

Abstract

Gastric cancer (GC) is a malignant tumor that affects individuals worldwide, and miRNA and mRNA are closely connected to this disease. However, it is still unclear how these molecules affect GC and whether their effects are associated with circRNA in GC patients. Therefore, we obtained the miRNA, mRNA and circRNA expression profiles of GC patients from the GEO database. For comparison, shared miRNAs and mRNAs from the results of microarrays were annotated by gene ontology (GO) and pathway analysis. We also identified mRNAs that were targeted by miRNA through TargetScan 7.2 and circRNAs that were targeted by miRNA through CircInteractome. A comprehensive analysis of the microarray results revealed 72 shared miRNAs, and the expression profiles of 6 miRNAs were significantly different between the tumor and control groups (the absolute value of fold change>2, P<0.05). Hsa-miR-1, hsa-miR-142-3p, hsa-miR-95, hsa-miR-133a and hsa-miR-181d were upregulated in GC, whereas hsa-miR-375 was downregulated. The analysis results also revealed 1201 shared mRNAs and 27 mRNAs, respectively, by microarray and TargetScan. Pathway analysis demonstrated that the Glypican pathway, Proteoglycan syndecan-mediated signalling events, Glypican 1 network and PAR1-mediated thrombin signalling events play important roles. GO analysis revealed significant enrichment in the three terms cellular component, molecular function and biological process, suggesting that organelles, enzyme binding, RNA-binding and nitrogen metabolism may have a strong relationship in GC. The increase in PAX6 in GC may be related to hsa-miR-375. Three circRNAs, hsa_circ_0001658, hsa_circ_0004928 and hsa_circ_0000376, were then found to be significantly differentially expressed between GC and normal tissues (the absolute value of fold change>2, P<0.05). In conclusion, the circ0001658/circ0004928/circ0000376-miR-375-PAX6 axis may represent a new regulatory network that should be further investigated, and the results of this study provide a better understanding of GC.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31307199     DOI: 10.4149/neo_2018_181211N952

Source DB:  PubMed          Journal:  Neoplasma        ISSN: 0028-2685            Impact factor:   2.575


  15 in total

1.  miR-4677-3p participates proliferation and metastases of gastric cancer cell via CEMIP-PI3K/AKT signaling pathway.

Authors:  Chen Mi; Dan Zhang; Yarui Li; Mudan Ren; Wenhui Ma; Guifang Lu; Shuixiang He
Journal:  Cell Cycle       Date:  2021-08-26       Impact factor: 5.173

2.  Circ_0000376, a Novel circRNA, Promotes the Progression of Non-Small Cell Lung Cancer Through Regulating the miR-1182/NOVA2 Network.

Authors:  Cui Li; Hai Liu; Qin Niu; Jia Gao
Journal:  Cancer Manag Res       Date:  2020-08-24       Impact factor: 3.989

3.  Hypoxia-induced miR-3677-3p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by suppressing SIRT5.

Authors:  Bowen Yao; Yazhao Li; Yongshen Niu; Liang Wang; Tianxiang Chen; Cheng Guo; Qingguang Liu
Journal:  J Cell Mol Med       Date:  2020-06-28       Impact factor: 5.310

4.  hsa_circ_0023409 Accelerates Gastric Cancer Cell Growth and Metastasis Through Regulating the IRS4/PI3K/AKT Pathway.

Authors:  Jian Li; Yongjing Yang; Dequan Xu; Ling Cao
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

5.  MiR-548d-3p Promotes Gastric Cancer by Targeting RSK4.

Authors:  Hui Liang; Cong Hu; Xu Lin; Zhuocheng He; Zhiwen Lin; Jun Dai
Journal:  Cancer Manag Res       Date:  2020-12-24       Impact factor: 3.989

6.  miR-133a-5p suppresses gastric cancer through TCF4 down-regulation.

Authors:  Mu-Qun He; Jian-Feng Wan; Hong-Fu Zeng; Ying-Yan Tang; Mu-Qing He
Journal:  J Gastrointest Oncol       Date:  2021-06

Review 7.  Molecular Alterations in Gastric Intestinal Metaplasia.

Authors:  Paulius Jonaitis; Limas Kupcinskas; Juozas Kupcinskas
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

8.  circCUL2 regulates gastric cancer malignant transformation and cisplatin resistance by modulating autophagy activation via miR-142-3p/ROCK2.

Authors:  Lei Peng; Huaiming Sang; Shuchun Wei; Yuanyuan Li; Duochen Jin; Xudong Zhu; Xuan Li; Yini Dang; Guoxin Zhang
Journal:  Mol Cancer       Date:  2020-11-05       Impact factor: 27.401

9.  Bupivacaine suppresses the progression of gastric cancer through regulating circ_0000376/miR-145-5p axis.

Authors:  Changqiao Ju; Jia Zhou; Hui Miao; Xin Chen; Qingyu Zhang
Journal:  BMC Anesthesiol       Date:  2020-10-30       Impact factor: 2.217

10.  MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis.

Authors:  Haiwei Ni; Hai Qin; Cheng Sun; Yichen Liu; Guojing Ruan; Qianqian Guo; Tao Xi; Yingying Xing; Lufeng Zheng
Journal:  Stem Cell Res Ther       Date:  2021-06-05       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.